HIVEP3 and acute myeloid leukemia: To further warrant the oncogenic potential of HIVEP3, we identified a series of immune checkpoints and ferroptosis‐related genes associated with HIVEP3 in AML patients via consensus clustering analyses based on the expression pattern of molecules involved in ferroptosis, immune microenvironment, and hypoxia.